Selecteer regio
Menu
  • Products and Solutionsmore
    • Intensive Care
    • Cardiovascular Procedures
    • Operating Room
    • Sterile Reprocessing
    • Digital Health
    • Pharmaceutical Production
    • Research Laboratories

    • View all products →
  • Servicesmore
    • Technische service
    • Digitale services
    • Financiële oplossingen
    • Planning en design
    • Projectimplementatie
    • Educatie en training
    • Strategische samenwerking

    • Bekijk alle services →
  • Insightsmore
    • Academy
    • Nieuws & expertise
    • Evenementen
    • Getinge Experience Center
    • Idea and invention submission

    • Insights main page →
  • Companymore
    • Corporate Governance
    • Duurzaamheid
    • Bedrijfsethiek
    • Persberichten
    • Careers
    • Investors
    • Grants en donaties
    • Geschiedenis

    • Company main page →
  • Loginmore
    • Instruction For Use and Patient Info
    • Getinge FleetView
    • ServiceNow
    • Distributor Portal
    • Hospital Planning Platform

    • Login page →
    • News
    • Legal Information
    • Instructions For Use/Patient Information
    • Product Catalog
    • COVID-19 Resource Center
    • Investors
    • Careers
  • Contact
  • Benelux (Nederlands)
    • Global
      • International (English)
    • EMEA
      • Sverige (Svenska)
      • Deutschland (Deutsch)
      • France (Français)
      • United Kingdom / Ireland (English)
      • Italia (Italiano)
      • Türkiye (Türkçe)
      • Polska (polski)
      • Россия (русский)
      • Spain (Español)
      • Denmark (Dansk)
      • Norge (Norsk)
      • Suomi (Suomalainen)
      • Benelux (Nederlands)
    • Americas
      • United States (English)
      • Brazil (Português)
      • Canada (English)
      • Canada (Français)
      • Latin America (Español)
    • Asia
      • 日本 (日本語)
      • 中国 (中文)
      • 한국어(대한민국)
      • South East Asia (English)
      • India (English)
    • Oceania
      • Australia / New Zealand (English)
  • Login
    • Instruction For Use and Patient Info
    • Getinge FleetView
    • ServiceNow
    • Distributor Portal
    • Hospital Planning Platform

    • Login page →
  • Products and Solutions
    • Intensive Care
    • Cardiovascular Procedures
    • Operating Room
    • Sterile Reprocessing
    • Digital Health
    • Pharmaceutical Production
    • Research Laboratories

    • View all products →
  • Services
    • Technische service
    • Digitale services
    • Financiële oplossingen
    • Planning en design
    • Projectimplementatie
    • Educatie en training
    • Strategische samenwerking

    • Bekijk alle services →
  • Insights
    • Academy
    • Nieuws & expertise
    • Evenementen
    • Getinge Experience Center
    • Idea and invention submission

    • Insights main page →
  • Company
    • Corporate Governance
    • Duurzaamheid
    • Bedrijfsethiek
    • Persberichten
    • Careers
    • Investors
    • Grants en donaties
    • Geschiedenis

    • Company main page →
  • Contact
  • Start
  • Company
  • Corporate Governance
  • General meetings

General meetings

The General Meeting of Shareholders is Getinge’s highest decision-making body through which the Shareholders exercise their influence over the company. The Annual General Meeting is held annually within six months of the end of the financial year and Shareholders can at the Annual General Meeting exercise their voting rights on various key matters. The Board can also convene and Extraordinary General Meeting.

  • Overview
  • Article of association
  • General meetings
  • Policies
  • Board of directors
  • Nomination committee
  • External auditor
  • Remuneration
  • Executive team
  • Corporate governance and auditor's reports
  • Board committees

Participation

Shareholders who wish to participate in and vote for their shares at the General Meeting must be registered in the share register and notify their participation.* Shareholders who are unable to attend in person may be represented by a proxy.

Location

Getinge's Annual General Meeting is held in Gothenburg or Halmstad no later than six months after the end of the financial year. The time and venue for the meeting are announced, at the latest, in connection with the interim report for the third quarter.

Notice to Attend

The notice to attend the General Meeting is published 4-6 weeks before the meeting in Post- och Inrikes Tidningar and on the company's website. An announcement that the notice to attend has been published is made in Svenska Dagbladet.

* The notice of participation to attend the General Meeting specifies how to give notice to the company and provides other information about participation in the General Meeting. The notice must be received within a certain time prior to the general meeting.

Matters at the Annual General Meeting

The Shareholders are informed about the development of the company during the past year. Key matters addressed at the Annual General Meeting are, for example, decisions made regarding the company and group's income statements and balance sheets, allocation of the company's profit, discharge from liability for the Board members and CEO, election of and remuneration for the Board members and the auditors, and any other issues in accordance with law or the articles of association.

Matters by request of Shareholders

A Shareholder is entitled to have a matter addressed at the General Meeting, provided that the board has received such request no later than one week before the notice to attend may be published at the earliest. The matter will be addressed also if the request is received later than said time, if the matter can be included in the notice to attend. A Shareholder who wishes to have a matter considered by the General Meeting must submit a written proposal to the meeting.

Extraordinary Shareholders Meeting

An Extraordinary General Meeting may be convened at the discretion of the Board of Directors, or if the auditors or a Shareholder who own no less then 10% of the shares request such meeting to be held. Matters to be handled on such meeting should be specified in writing in the request.

Annual General Meeting 2025

Read more

Annual General Meeting 2024

Read more

Annual General Meeting 2023

Read more

Annual General Meeting 2022

Read more

Annual General Meeting 2021

Read more

Annual General Meeting 2020

Read more

Annual General Meeting 2019

Read more

Annual General Meeting 2018

Read more

Extraordinary General Meeting December 2017

Read more

Extraordinary General Meeting August 2017

Read more

Annual General Meeting 2017

Read more

Annual General Meeting 2016

Read more

Annual General Meeting 2015

Read more

Annual General Meeting 2014

Read more

Annual General Meeting 2013

Read more

Annual General Meeting 2012

Read more

Annual General Meeting 2011

Read more

Annual General Meeting 2010

Read more

Annual General Meeting 2009

Read more

U verlaat nu Getinge.com. U kunt toegang krijgen tot inhoud die niet door het Getinge-team wordt beheerd. In dat geval kan Getinge niet verantwoordelijk worden gehouden voor de inhoud.

Ik begrijp het!

Ons aanbod

  • Products and Solutions
  • Services

Support

  • Insights
  • Evenementen
  • Past Webinars
  • Instructions For Use/Patient Information
  • Security

Over ons

  • Investeerders
  • Carrière
  • Corporate Governance
  • Geschiedenis
  • Juridische informatie
  • Privacyverklaring website
  • Cookieverklaring
  • Data Subject Request Form
Neem contact op
Benelux (Nederlands)
  • Global
    • International (English)
  • EMEA
    • Sverige (Svenska)
    • Deutschland (Deutsch)
    • France (Français)
    • United Kingdom / Ireland (English)
    • Italia (Italiano)
    • Türkiye (Türkçe)
    • Polska (polski)
    • Россия (русский)
    • Spain (Español)
    • Denmark (Dansk)
    • Norge (Norsk)
    • Suomi (Suomalainen)
    • Benelux (Nederlands)
  • Americas
    • United States (English)
    • Brazil (Português)
    • Canada (English)
    • Canada (Français)
    • Latin America (Español)
  • Asia
    • 日本 (日本語)
    • 中国 (中文)
    • 한국어(대한민국)
    • South East Asia (English)
    • India (English)
  • Oceania
    • Australia / New Zealand (English)
Benelux (Nederlands)

© 2024 Getinge │ Getinge en
 
Getinge_Logo_hz_RGB_neg.png

zijn handelsmerken of geregistreerde handelsmerken van Getinge AB, haar dochterondernemingen of gelieerde ondernemingen │Alle rechten voorbehouden.

november 2024

Deze informatie is uitsluitend gericht op beroepsbeoefenaren in de gezondheidszorg of een ander professioneel publiek en is alleen bedoeld voor informatieve doeleinden, is niet uitputtend en mag daarom niet worden gebruikt als vervanging van de gebruiksaanwijzing, de servicehandleiding of medisch advies. Getinge draagt geen verantwoordelijkheid of aansprakelijkheid voor enig handelen of nalaten van welke partij dan ook op basis van dit materiaal, en vertrouwen is uitsluitend voor risico van de gebruiker.

Het is mogelijk dat een genoemde therapie, oplossing of product niet beschikbaar of toegestaan is in uw land. Informatie mag niet geheel of gedeeltelijk worden gekopieerd of gebruikt zonder schriftelijke toestemming van Getinge.

Deze informatie is bedoeld voor een internationaal publiek buiten de VS.

De weergegeven standpunten, meningen en beweringen zijn uitsluitend die van de geïnterviewden en weerspiegelen of vertegenwoordigen niet noodzakelijkerwijs de standpunten van Getinge.